Image
|
Figure Caption
Fig. 9 Oxytocin receptor agonist increases ERK1/2 phosphorylation. The compound WAY-267464 did not impact AKT phosphorylation (a), but when used at a dosage of 50 μM, it was found to enhance ERK1/2 phosphorylation (b). Data were analysed using a t-test (a: 100 μM, b: 50 μM). Mann–Whitney test was used for datasets that failed normality testing or had significantly different variances (a: 50 μM, b: 100 μM). The confidence limit of *p < 0.05 was considered statistically significant, n = 5–7.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ J. Psychopharmacol. (Oxford)